SMS Lifesciences India Limited announced the re-appointment of Veeravenkata Satyanarayana Murthy Talluri (TVVSN Murthy) as Managing Director of the company, with effect from June 1, 2022..
According to the company’s exchange filing, “the Board of Directors of the Company, at its Meeting held on May 28, 2022 has approved the reappointment of Mr. Veeravenkata Satyanarayana Murthy Talluri (DIN: 00465198) as Managing Director of the Company for a further period of 3 (three) consecutive years w.e.1. June 1, 2022, subject to the approval of Shareholders in the ensuing Meeting.”
Murthy is a Graduate in Chemistry and has a rich experience in the bulk drug and pharmaceutical industry. He began his career in 1981 with Standard Organics Limited. Hyderabad. as a chemist in the R&D dept. During this period. he was instrumental in developing technologies and processes for several bulk drugs. He was actively involved in the commercialization of products by scaling up the laboratory-scale process to pilot plant and up to commercial scales.
In 1984. he joined Cheminor Drugs Limited (Group of Dr. Reddy’s Limited Laboratory). Hyderabad as Production Manager. He played a major role in the substantial development of production and turnover. He also played a key role in getting US-FDA approval for Cheminor Drugs Limited; as a production Manager. he contributed a lot to process improvement and cost reduction procedures and to increasing labor productivity by motivation.
He has been with SMS Pharmaceuticals Limited since 1990. He played a vital role in developing the production and R& D activities of SMS Pharma. He also played a major part in reducing the Ranitidine production Process from 7 stages to 4 stages. He has vast experience in the pharmaceutical industry.
He has been associated with SMS Lifesciences India Limited since 2016 as Managing Director of the Company, under his able guidance, the Company has lately completed the USFDA audit with Nil observations, the statement said.
SMS Lifesciences focuses on manufacturing, buying, selling, importing, and exporting of chemicals, pharmaceuticals, pharmaceutical ingredients, and intermediates.
HrNxt.com Newsdesk has researchers and writers with an excellent domain knowledge about the talent ecosystem, and the business environment. The team keeps a tab on the latest happenings in the ecosystem to bring most relevant news and insights for our readers. You can connect with our newsdesk at newsdesk@hrnxt.com.